975 related articles for article (PubMed ID: 19184068)
1. Mechanisms of tau-induced neurodegeneration.
Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
Iqbal K; Grundke-Iqbal I
J Cell Mol Med; 2008; 12(1):38-55. PubMed ID: 18194444
[TBL] [Abstract][Full Text] [Related]
3. Tau pathology in Alzheimer disease and other tauopathies.
Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
Iqbal K; Alonso AD; Gondal JA; Gong CX; Haque N; Khatoon S; Sengupta A; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 2000; 59():213-22. PubMed ID: 10961432
[TBL] [Abstract][Full Text] [Related]
6. Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tsujio I; Wang JZ; Grundke-Iqbal I
J Mol Neurosci; 2002; 19(1-2):95-9. PubMed ID: 12212801
[TBL] [Abstract][Full Text] [Related]
7. Tau in Alzheimer disease and related tauopathies.
Iqbal K; Liu F; Gong CX; Grundke-Iqbal I
Curr Alzheimer Res; 2010 Dec; 7(8):656-64. PubMed ID: 20678074
[TBL] [Abstract][Full Text] [Related]
8. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tanimukai H; Tsujio I; Wang JZ; Grundke-Iqba I
J Mol Neurosci; 2003; 20(3):425-9. PubMed ID: 14501027
[TBL] [Abstract][Full Text] [Related]
10. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
Vingtdeux V; Davies P; Dickson DW; Marambaud P
Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological approaches of neurofibrillary degeneration.
Iqbal K; Grundke-Iqbal I
Curr Alzheimer Res; 2005 Jul; 2(3):335-41. PubMed ID: 15974899
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic abnormally hyperphosphorylated tau but not paired helical filaments sequester normal MAPs and inhibit microtubule assembly.
Iqbal K; Alonso Adel C; Grundke-Iqbal I
J Alzheimers Dis; 2008 Aug; 14(4):365-70. PubMed ID: 18688085
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathies.
Iqbal K; Grundke-Iqbal I
Curr Drug Targets; 2004 Aug; 5(6):495-502. PubMed ID: 15270196
[TBL] [Abstract][Full Text] [Related]
14. Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity.
Alonso Adel C; Li B; Grundke-Iqbal I; Iqbal K
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8864-9. PubMed ID: 16735465
[TBL] [Abstract][Full Text] [Related]
15. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Tsujio I; Grundke-Iqbal I
J Neural Transm Suppl; 2002; (62):309-19. PubMed ID: 12456074
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial.
Iqbal K; Wang X; Blanchard J; Liu F; Gong CX; Grundke-Iqbal I
Biochem Soc Trans; 2010 Aug; 38(4):962-6. PubMed ID: 20658985
[TBL] [Abstract][Full Text] [Related]
18. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
19. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
20. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau.
Alonso AD; Grundke-Iqbal I; Barra HS; Iqbal K
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):298-303. PubMed ID: 8990203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]